metopimazine
Small moleculeexperimental
Clinical trial activity
1 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 15, 2019 (NCT03935321)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Dopamine D2 receptorANTAGONIST
DRD2 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03935321 | Phase 2 | May 15, 2019 | European Commission, Foundation Wings For Life, Government of Switzerland, Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien, Swiss Paraplegic Research, University of Heidelberg, University of Zurich |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Commission | Government | 1 | 0 | 1 | 2019 |
| Foundation Wings For Life | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Government of Switzerland | Government | 1 | 0 | 1 | 2019 |
| Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Swiss Paraplegic Research | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Heidelberg | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2019 |
7 organizations
Page 1 / 1